In the August Newsletter, you'll find an update from IASLC President Dr. Peter Goldstraw and IASLC Executive Director Dr. Paul A. Bunn, Jr. The edition also provides information on the recent IASLC election, which establishes the upcoming Officer and Board of Directors; the latest fellowship opportunities; details on IASLC Events; the latest work by IASLC Committees; the latest offer to fellows to join the IASLC and recent new moves by our members.
Election of IASLC officers and members of the Board of Directors are ongoing and the deadline is July 16, 2013.
The World Conference on Lung Cancer in Sydney is coming closer - October 27-30, 2013. A record high number, more than 2,300, of abstracts have been received for the conference and will now be evaluated by the Program Committee. Notification to the abstract authors is scheduled to July 26, 2013. Please, take advantage of the early registration with the deadline of August 2, 2013.
IASLC Election for officers and members of the Board of Directors is approaching. Please see instructions below. The election process will start June 11 and run through July 16, 2013.
The World Conference on Lung Cancer in Sydney is coming closer - October 27-30, 2013. Please note that the deadline for abstract is June 21, 2013 and we hope as many members as possible will submit abstracts. Please refer to www.iaslc.org for more information. The IASLC would like to draw your attention to the special travel awards offered to the patient’s advocates.
The World Conference on Lung Cancer in Sydney is coming closer, October 27-30, 2013. A very exciting program has been established by the program committee and particularly the two Conference Presidents, Drs. Michael Boyer and Kwun Fong. Please note that the deadline for abstract is June 21, 2013 and we hope as many members as possible will submit abstracts. The IASLC would like to draw your attention to the special travel awards offered to the patient’s advocates.
A significant step towards implementation of personalized medicine for lung cancer patients is the recent publication of the CAP/IASLC/AMP Guidelines for Molecular Testing. The IASLC is proud to be a part of this development, which should improve patient care and secure the many patients with lung cancer the most optimal therapy based on standardized and validated molecular tests. The IASLC is currently putting considerable effort into implementing these guidelines in clinical practice.
We hope all of you enjoyed good holidays and are now ready for a productive 2013 IASLC year!
The World Conference in Sydney is approaching soon, and abstract submission is now open. Embedded in the program are many educational activities for younger colleagues, together with the scientific program.
As most of us are approaching the holidays, the IASLC is continuing the many activities. The deadline for the new IASLC Fellowship program is January 16, 2013. We encourage as many as possible to apply for this great opportunity.
The Heine H. Hansen fellowships were launched in celebration of the IASLC 40th year anniversary. We hope many of the IASLC members will support this effort to stimulate career development for the next generation lung cancer investigators!